EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-SA 4.0

Identification of human papillomavirus and Rb/E2F pathway genomic alterations in mixed adeno-neuroendocrine carcinoma

Feng Ling, Zhihui Yang

Indian Journal of Pathology and Microbiology · 2025

DOI: 10.4103/ijpm.ijpm_511_23 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Indian Journal of Pathology and Microbiology, 2025. Verfasst von Feng Ling und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, The Affiliated Hospital of Southwest Medical University, Luzhou, China. Hauptthemen laut MEDLINE: Retinoblastoma Protein, Papillomavirus Infections, Carcinoma, Neuroendocrine, Papillomaviridae. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-SA 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To investigate the molecular characteristics of Rb/E2F in mixed adeno-neuroendocrine carcinoma (MANEC). Materials and Methods: The clinicopathological features of MANEC were analyzed. The protein expressions of Rb, p16, and p53 were detected by the immunohistochemical method. The infection status of high-risk human papillomavirus (HR-HPV) was evaluated by in situ hybridization (ISH) and the gene chip method.

Results

Thirteen cases of MANEC were divided into four molecular patterns according to Rb protein expression and HPV status. Group 1: A total of eight of the 13 cases showed positive Rb protein expression and lack of HR-HPV expression (8/13, 62%). Rb protein expression with p16 protein deletion and p53 protein abnormal expression was unique to NEC. Group 2: three cases (3/13, 23%) with negative Rb protein expression and lack of HR-HPV expression. Group 3: There was one case (1/13, 8%) with positive expression of Rb protein accompanied by HR-HPV. Group 4: There was one case of Rb protein loss with an HR-HPV-positive status.

Conclusions

HR-HPV and Rb/p16/p53 pathway can be associated in MANEC pathogenesis, which provides the research basis for personalized treatment of MANEC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Retinoblastoma ProteinPapillomavirus InfectionsCarcinoma, NeuroendocrinePapillomaviridaeE2F Transcription FactorsAdenocarcinomaHumansMaleMiddle AgedFemaleAdultAgedImmunohistochemistryTumor Suppressor Protein p53Cyclin-Dependent Kinase Inhibitor p16In Situ HybridizationHuman Papillomavirus Viruses

Substanzen

Retinoblastoma ProteinTumor Suppressor Protein p53Cyclin-Dependent Kinase Inhibitor p16E2F Transcription Factors

Autor:innen und Institutionen

  • Department of Pathology, The Affiliated Hospital of Southwest Medical University, Luzhou, China.
  • Precision Pathology Diagnosis for Serious Diseases Key Laboratory of LuZhou, China.

Zitieren

APA

Ling, F., & Yang, Z. (2025). Identification of human papillomavirus and Rb/E2F pathway genomic alterations in mixed adeno-neuroendocrine carcinoma. Indian Journal of Pathology and Microbiology. https://doi.org/10.4103/ijpm.ijpm_511_23

Vancouver

Ling F, Yang Z. Identification of human papillomavirus and Rb/E2F pathway genomic alterations in mixed adeno-neuroendocrine carcinoma. Indian Journal of Pathology and Microbiology. 2025. doi:10.4103/ijpm.ijpm_511_23

BibTeX
@article{Ling2025,
  author = {Ling, Feng and Yang, Zhihui},
  title = {Identification of human papillomavirus and Rb/E2F pathway genomic alterations in mixed adeno-neuroendocrine carcinoma},
  journal = {Indian Journal of Pathology and Microbiology},
  year = {2025},
  doi = {10.4103/ijpm.ijpm_511_23}
}
Kostenlos starten →